| pubmed-article:11922905 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11922905 | lifeskim:mentions | umls-concept:C0178324 | lld:lifeskim |
| pubmed-article:11922905 | lifeskim:mentions | umls-concept:C0055023 | lld:lifeskim |
| pubmed-article:11922905 | lifeskim:mentions | umls-concept:C2936381 | lld:lifeskim |
| pubmed-article:11922905 | lifeskim:mentions | umls-concept:C0332206 | lld:lifeskim |
| pubmed-article:11922905 | lifeskim:mentions | umls-concept:C1292733 | lld:lifeskim |
| pubmed-article:11922905 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:11922905 | pubmed:dateCreated | 2002-3-29 | lld:pubmed |
| pubmed-article:11922905 | pubmed:abstractText | Smooth muscle cell (SMC) migration involves interactions with extracellular matrix (ECM) and is an important process in response to arterial wall injury. We investigated the expression and the functional role of vitronectin (VN) in the response after vascular injury. | lld:pubmed |
| pubmed-article:11922905 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11922905 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11922905 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11922905 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11922905 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11922905 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11922905 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11922905 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11922905 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11922905 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:11922905 | pubmed:issn | 0008-6363 | lld:pubmed |
| pubmed-article:11922905 | pubmed:author | pubmed-author:DaretDanièleD | lld:pubmed |
| pubmed-article:11922905 | pubmed:author | pubmed-author:DufourcqPasca... | lld:pubmed |
| pubmed-article:11922905 | pubmed:author | pubmed-author:CouffinhalThi... | lld:pubmed |
| pubmed-article:11922905 | pubmed:author | pubmed-author:AlzieuPhilipe... | lld:pubmed |
| pubmed-article:11922905 | pubmed:author | pubmed-author:MoreauCatheri... | lld:pubmed |
| pubmed-article:11922905 | pubmed:author | pubmed-author:DuplàaCécileC | lld:pubmed |
| pubmed-article:11922905 | pubmed:author | pubmed-author:BonnetJacques... | lld:pubmed |
| pubmed-article:11922905 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11922905 | pubmed:volume | 53 | lld:pubmed |
| pubmed-article:11922905 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11922905 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11922905 | pubmed:pagination | 952-62 | lld:pubmed |
| pubmed-article:11922905 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11922905 | pubmed:meshHeading | pubmed-meshheading:11922905... | lld:pubmed |
| pubmed-article:11922905 | pubmed:meshHeading | pubmed-meshheading:11922905... | lld:pubmed |
| pubmed-article:11922905 | pubmed:meshHeading | pubmed-meshheading:11922905... | lld:pubmed |
| pubmed-article:11922905 | pubmed:meshHeading | pubmed-meshheading:11922905... | lld:pubmed |
| pubmed-article:11922905 | pubmed:meshHeading | pubmed-meshheading:11922905... | lld:pubmed |
| pubmed-article:11922905 | pubmed:meshHeading | pubmed-meshheading:11922905... | lld:pubmed |
| pubmed-article:11922905 | pubmed:meshHeading | pubmed-meshheading:11922905... | lld:pubmed |
| pubmed-article:11922905 | pubmed:meshHeading | pubmed-meshheading:11922905... | lld:pubmed |
| pubmed-article:11922905 | pubmed:meshHeading | pubmed-meshheading:11922905... | lld:pubmed |
| pubmed-article:11922905 | pubmed:meshHeading | pubmed-meshheading:11922905... | lld:pubmed |
| pubmed-article:11922905 | pubmed:meshHeading | pubmed-meshheading:11922905... | lld:pubmed |
| pubmed-article:11922905 | pubmed:meshHeading | pubmed-meshheading:11922905... | lld:pubmed |
| pubmed-article:11922905 | pubmed:meshHeading | pubmed-meshheading:11922905... | lld:pubmed |
| pubmed-article:11922905 | pubmed:meshHeading | pubmed-meshheading:11922905... | lld:pubmed |
| pubmed-article:11922905 | pubmed:meshHeading | pubmed-meshheading:11922905... | lld:pubmed |
| pubmed-article:11922905 | pubmed:meshHeading | pubmed-meshheading:11922905... | lld:pubmed |
| pubmed-article:11922905 | pubmed:meshHeading | pubmed-meshheading:11922905... | lld:pubmed |
| pubmed-article:11922905 | pubmed:meshHeading | pubmed-meshheading:11922905... | lld:pubmed |
| pubmed-article:11922905 | pubmed:meshHeading | pubmed-meshheading:11922905... | lld:pubmed |
| pubmed-article:11922905 | pubmed:meshHeading | pubmed-meshheading:11922905... | lld:pubmed |
| pubmed-article:11922905 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:11922905 | pubmed:articleTitle | Vitronectin is up-regulated after vascular injury and vitronectin blockade prevents neointima formation. | lld:pubmed |
| pubmed-article:11922905 | pubmed:affiliation | Institut National de la Santé et de la Recherche Médicale, INSERM Unité 441, Athéroclérose, Avenue du Haut-Lévêque, 33600 Pessac, France. pascale.dufourcq@biophar.u-bordeaux2.fr | lld:pubmed |
| pubmed-article:11922905 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11922905 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| entrez-gene:296456 | entrezgene:pubmed | pubmed-article:11922905 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11922905 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11922905 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11922905 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11922905 | lld:pubmed |
